India's Narcotics Control Bureau seized approximately 227.7 kg [1] of Captagon tablets and powder during a targeted enforcement action.

The operation marks a significant effort to dismantle an international trafficking syndicate. Authorities said they aim to prevent the distribution of the stimulant in Middle East and Gulf markets, where the drug is widely circulated.

Agents conducted the seizure as part of a mission titled Operation Ragepill [1]. During the proceedings, officials said they arrested one individual, identified as a Syrian national who was overstaying his visa in India [1].

The seized shipment, consisting of both tablets and powder, carries an estimated market value of ₹182 crore [2]. This bust represents the first major seizure of Captagon in India, highlighting a shift in the types of narcotics traversing the region's borders.

Captagon is a synthetic stimulant often associated with conflict zones. The NCB's intervention targeted the logistics of a network designed to move the substance across international lines, a move intended to disrupt the financial and operational capabilities of the syndicate [1, 2].

“India's Narcotics Control Bureau seized approximately 227.7 kg of Captagon tablets and powder.”

The seizure of Captagon in India indicates that the country is being utilized as a transit hub for synthetic stimulants destined for the Middle East. By intercepting a shipment of this volume, the NCB is signaling a strategic shift toward disrupting non-traditional narcotic routes that link West Asia to the Indian subcontinent.